MedPath
HSA Approval

LACTUS SYRUP 66% w/v

SIN10132P

LACTUS SYRUP 66% w/v

LACTUS SYRUP 66% w/v

October 2, 1998

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantICM PHARMA PTE. LTD.
Licence HolderICM PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

A06AD11

lactulose

Manufacturer Information

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Active Ingredients

LACTULOSE

66% w/v

Lactulose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LACTUS SYRUP 66% w/v - HSA Approval | MedPath